Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | NEO2734 |
| Trade Name | |
| Synonyms | NEO 2734|EP31670|EP-31670|NEO-2734|EP36170 |
| Drug Descriptions |
NEO 2734 is a dual inhibitor of the BET and CBP/P300 which potentially inhibits tumor growth (Ann Oncol, 29(suppl_8), Oct 2018, abstract 429P, PMID: 32371576). |
| DrugClasses | BET Inhibitor (Pan) 33 CBP/p300 inhibitor 13 |
| CAS Registry Number | NA |
| NCIT ID | C190126 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Enzalutamide + NEO2734 | Enzalutamide NEO2734 | 0 | 0 |
| NEO2734 | NEO2734 | 0 | 1 |
| NEO2734 + Palbociclib | NEO2734 Palbociclib | 0 | 0 |